Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

John Gribben

Showing results (41-50 of 104) with videos related to

Pageof 11
Sort By:
Nature Reviews. Disease Primers|February 10, 2017
Chronic lymphocytic leukaemiaThomas J Kipps, Freda K Stevenson, Catherine J Wu, et al.
Blood|October 11, 2014
Managing high-risk CLL during transition to a new treatment era: stem cell transplantation or novel agents?Peter Dreger, Johannes Schetelig, Niels Andersen, et al.
Nature Reviews. Disease Primers|January 20, 2017
Chronic lymphocytic leukaemiaThomas J Kipps, Freda K Stevenson, Catherine J Wu, et al.
Scientific Reports|September 19, 2019
Phenotypic characterisation of regulatory T cells in dogs reveals signature transcripts conserved in humans and miceYing Wu, Yu-Mei Chang, Anneliese J Stell, et al.
Clinical Lymphoma, Myeloma & Leukemia|March 13, 2010
Optimal use of bendamustine in chronic lymphocytic leukemia, non-Hodgkin lymphomas, and multiple myeloma: treatment recommendations from an international consensus panelBruce D Cheson, Clemens-Martin Wendtner, Angelika Pieper, et al.
Pain|August 22, 2019
A randomized pilot study to investigate the effect of opioids on immunomarkers using gene expression profiling during surgeryTheresa Wodehouse, Mary Demopoulos, Robert Petty, et al.
British Journal of Haematology|December 31, 2013
Psychosocial factors associated with impact of cancer in longterm haematological cancer survivorsAnia Korszun, Shah-Jalal Sarker, Kashfia Chowdhury, et al.
British Journal of Haematology|March 13, 2021
Reduced intensity allogeneic hematopoietic stem cell transplantation is a safe and effective treatment option in high-risk myeloma patients - a single centre experienceAmanda Jurgensen-Rauch, Suzanne Gibbs, Maresa Farrell, et al.
Hemasphere|August 15, 2022
How a Medical Association Can Make a Difference in a Crisis SituationNathalie van Havre, Enrica Orsini, Antonio Almeida, et al.
The Journal of Clinical Investigation|May 5, 2020
Mesenchymal niche remodeling impairs hematopoiesis via stanniocalcin 1 in acute myeloid leukemiaAlexander Waclawiczek, Ashley Hamilton, Kevin Rouault-Pierre, et al.
Pageof 11

Showing results (41-50 of 104) with videos related to

Sort By:
Pageof 11
Nature Reviews. Disease Primers|February 10, 2017
Chronic lymphocytic leukaemiaThomas J Kipps, Freda K Stevenson, Catherine J Wu, et al.
Blood|October 11, 2014
Managing high-risk CLL during transition to a new treatment era: stem cell transplantation or novel agents?Peter Dreger, Johannes Schetelig, Niels Andersen, et al.
Nature Reviews. Disease Primers|January 20, 2017
Chronic lymphocytic leukaemiaThomas J Kipps, Freda K Stevenson, Catherine J Wu, et al.
Scientific Reports|September 19, 2019
Phenotypic characterisation of regulatory T cells in dogs reveals signature transcripts conserved in humans and miceYing Wu, Yu-Mei Chang, Anneliese J Stell, et al.
Clinical Lymphoma, Myeloma & Leukemia|March 13, 2010
Optimal use of bendamustine in chronic lymphocytic leukemia, non-Hodgkin lymphomas, and multiple myeloma: treatment recommendations from an international consensus panelBruce D Cheson, Clemens-Martin Wendtner, Angelika Pieper, et al.
Pain|August 22, 2019
A randomized pilot study to investigate the effect of opioids on immunomarkers using gene expression profiling during surgeryTheresa Wodehouse, Mary Demopoulos, Robert Petty, et al.
British Journal of Haematology|December 31, 2013
Psychosocial factors associated with impact of cancer in longterm haematological cancer survivorsAnia Korszun, Shah-Jalal Sarker, Kashfia Chowdhury, et al.
British Journal of Haematology|March 13, 2021
Reduced intensity allogeneic hematopoietic stem cell transplantation is a safe and effective treatment option in high-risk myeloma patients - a single centre experienceAmanda Jurgensen-Rauch, Suzanne Gibbs, Maresa Farrell, et al.
Hemasphere|August 15, 2022
How a Medical Association Can Make a Difference in a Crisis SituationNathalie van Havre, Enrica Orsini, Antonio Almeida, et al.
The Journal of Clinical Investigation|May 5, 2020
Mesenchymal niche remodeling impairs hematopoiesis via stanniocalcin 1 in acute myeloid leukemiaAlexander Waclawiczek, Ashley Hamilton, Kevin Rouault-Pierre, et al.
Pageof 11